This graph shows the total stem cell research funding by the National Institutes for Health (NIH) from FY 2013 to FY 2025. In fiscal year 2015, stem cell research funding by the NIH was around 1.43 billion U.S. dollars. It is estimated that in FY 2024 it will reach 2.22 billion U.S. dollars.

This statistic is based on a survey conducted in January 2017. It shows U.S. adults' opinion on expanding government spending for medical research using embryonic stem cells. Some 24 percent of respondents somewhat favored increasing government funding for research using stem cells.

ABSTRACTThis study explores the development of laypeople's preferences for newly emerging climate engineering technology (CE). It examines whether laypeople perceive CE to be an acceptable back-up strategy (plan B) if current efforts to mitigate CO2 emissions were to fail. This idea is a common justification for CE research in the scientific debate and may significantly influence future public debates. Ninety-eight German participants chose their preferred climate policy strategy in a quasi-realistic scenario. Participants could chose between mitigation and three CE techniques as alternative options. We employed a think-aloud interview technique, which allowed us to trace participants’ informational needs and thought processes. Drawing on Huber's risk management decision theory, the study addressed whether specific CE options are more likely to be accepted if they are mentally represented as a back-up strategy. Results support this assumption, especially for cloud whitening. This result is especially relevant considering the high prevalence of the plan B framing in CE appraisal studies and its implications for public opinion-formation processes.

The Consumer Electronics MLCC Market is segmented by Device Type (Air Conditioner, Desktop PCs, Gaming Console, HDDs and SSDs, Laptops, Printers, Refrigerator, Smartphones, Smartwatches, Tablets, Television, Others), by Case Size (0 201, 0 402, 0 603, 1 005, 1 210, Others), by Voltage (10V to 30V, Above 30V, Less than 10V), by Capacitance (10 μF to 100 μF, Less than 10 μF, More than 100 μF), by Dielectric Type (Class 1, Class 2) and by Region (Asia-Pacific, Europe, North America). Market Value in USD and Market Volume in million units is presented. Key Data Points observed include raw material price trends, automotive sales, consumer electronics sales, and EV Sales etc.

The Single-Cell Analysis Transcriptomics Market Report is Segmented by Component (Equipment, Consumables, Software and Services), by Technology (Sequencing, Polymerase Chain Reaction (PCR), Microarray, Others), by Application (Clinical Diagnostics, Drug Discovery, and Others), by End-User (Academic & Research Institutions, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value (in USD) for the Above Segments.

The global single-cell analysis Market is expected to witness a growth rate of 14% in the next five years. Continuous innovations in single-cell analysis techniques; rising incidence of cancer and other chronic & infectious diseases; growing shift towards personalized medicine; expansion of the biotechnology and pharmaceutical industries; significant funding and investments for research and development […]

United States GDP: 2009p: saar: QoQ%: GCI: CE: GI: IP: Research & Development data was reported at 0.700 % in Mar 2018. This records an increase from the previous number of -8.100 % for Dec 2017. United States GDP: 2009p: saar: QoQ%: GCI: CE: GI: IP: Research & Development data is updated quarterly, averaging 3.250 % from Jun 1947 (Median) to Mar 2018, with 284 observations. The data reached an all-time high of 36.500 % in Mar 1956 and a record low of -9.600 % in Mar 1970. United States GDP: 2009p: saar: QoQ%: GCI: CE: GI: IP: Research & Development data remains active status in CEIC and is reported by Bureau of Economic Analysis. The data is categorized under Global Database’s United States – Table US.A132: NIPA 2013: GDP by Expenditure: Chain Linked 2009 Price: saar: QoQ%.

The Fuel Cell for Data Center Market is set to grow at 16% CAGR, reaching USD 400 Million by 2030 from USD 175 Million in 2024. Discover key insights and trends here!

Market Overview:

The United States 3D cell culture market size is projected to exhibit a growth rate (CAGR) of 14.10% during 2024-2032. The growing recognition of the limitations of traditional 2D cell cultures, the convergence of advanced technologies with 3D cell culture, and various investments in biomedical research and innovation represent some of the key factors driving the market.

3D cell culture refers to a cutting-edge technique used in biomedical research to cultivate and study cells in a three-dimensional environment that closely mimics the complexity of human tissues. Unlike traditional 2D cell cultures, which grow cells in flat, monolayer formats, 3D cell culture involves providing structural support for cells to grow and interact in three dimensions. This is achieved by using scaffold materials such as hydrogels, biocompatible polymers, or other matrices that enable cells to form intricate and lifelike tissue-like structures. The primary goal of 3D cell culture is to create in vitro conditions that more closely resemble the natural environment within the human body. This approach allows researchers to study cellular behavior, interactions, and responses to stimuli in a more physiologically relevant context. It is particularly valuable for various fields of biomedical research, including cancer biology, regenerative medicine, and drug development, as it provides a closer approximation of how cells behave within the human body. This dynamic and three-dimensional cellular environment offers researchers a more accurate platform to investigate disease mechanisms, test potential drug candidates, and gain insights into tissue development and regeneration.

United States 3D Cell Culture Market Trends:

One of the primary drivers is the growing recognition of the limitations of traditional 2D cell cultures in replicating the complexity of human tissues. Researchers and pharmaceutical companies are increasingly turning to 3D cell culture models to bridge the gap between in vitro and in vivo experiments, seeking more accurate and predictive models for drug testing and disease research. In addition, the convergence of advanced technologies with 3D cell culture systems has accelerated the market's growth. High-throughput screening, advanced imaging techniques, microfluidics, and automation are being integrated into 3D cell culture workflows, enabling researchers to conduct more sophisticated experiments, such as real-time monitoring of cell behavior within 3D structures and high-content screening of drug candidates. Besides, the United States government continues to provide substantial support for biomedical research and innovation. Research grants, initiatives aimed at accelerating drug development, and collaborations between academia and industry are all contributing to the expansion of the 3D cell culture market. This support encourages both fundamental research and the development of innovative 3D cell culture products and services. Moreover, pharmaceutical and biotechnology companies are increasingly adopting 3D cell culture models as an integral part of their drug discovery and development pipelines. These models offer the potential to reduce late-stage drug failures, lower research and development costs, and enhance the predictability of drug responses, driving their widespread adoption within the industry. Furthermore, the market is witnessing a surge in the development of 3D cell culture products and services. Industry leaders and startups are actively innovating and introducing user-friendly, standardized 3D cell culture kits, platforms, and assays. This competitive environment is fostering innovation and making 3D cell culture more accessible to a broader range of researchers, further propelling market growth.

United States 3D Cell Culture Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on product, application, and end user.

Product Insights:

https://www.imarcgroup.com/CKEditor/43460aa0-0576-4cfb-b1de-0f9ccb49394dother-regions1.webp" style="height:450px; width:800px" />

• Scaffold-Based Platforms
• Scaffold-Free Platforms
• Microchips
• Bioreactors
• Others
  

The report has provided a detailed breakup and analysis of the market based on the product. This includes scaffold-based platforms, scaffold-free platforms, microchips, bioreactors, and others.

Application Insights:

• Cancer Research
• Stem Cell Research
• Drug Discovery
• Regenerative Medicine
• Others
  

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes cancer research, stem cell research, drug discovery, regenerative medicine, and others.

End User Insights:

• Biotechnology and Pharmaceutical Companies
• Contract Research Laboratories
• Academic Institutes
• Others
  

The report has provided a detailed breakup and analysis of the market based on the end user. This includes biotechnology and pharmaceutical companies, contract research laboratories, academic institutes, and others.

Regional Insights:

https://www.imarcgroup.com/CKEditor/c898201f-9f4e-4c8d-868c-e0af55e26cfbother-regions8.webp" style="height:450px; width:800px" />

• Northeast
• Midwest
• South
• West
  

The report has also provided a comprehensive analysis of all the major regional markets, which include Northeast, Midwest, South, and West.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

United States 3D Cell Culture Market Report Coverage:

Microfluidic Cell Sorter Market Outlook

The global microfluidic cell sorter market size was valued at approximately USD 1.2 billion in 2023 and is expected to reach around USD 3.8 billion by 2032, growing at a CAGR of 13.5% during the forecast period. This rapid growth is largely attributed to advancements in biotechnology and increasing research and development activities in the pharmaceutical sector. The growing demand for precision medicine and the rising prevalence of chronic and infectious diseases are significant factors driving market growth.

The rising prevalence of chronic and infectious diseases necessitates the development and utilization of advanced diagnostic and therapeutic technologies. Microfluidic cell sorters play a critical role in these processes by enabling the efficient and accurate sorting of cells. This is essential for various applications, including stem cell research, cancer diagnostics, and personalized medicine. The aging global population and the increasing incidence of diseases such as cancer, diabetes, and cardiovascular conditions further bolster the demand for advanced cell sorting technologies.

Technological advancements in microfluidics and cell sorting technologies are another key growth driver for this market. Innovations such as the integration of artificial intelligence (AI) and machine learning (ML) in microfluidic devices enhance their accuracy, efficiency, and speed. Furthermore, the development of portable and user-friendly devices makes these technologies accessible to a broader range of end-users, including smaller research laboratories and hospitals. The continuous improvement in technology is expected to drive significant growth in the microfluidic cell sorter market over the forecast period.

Government and private sector investments in the biotechnology and pharmaceutical industries are also fueling market growth. Increased funding for research and development activities and the establishment of new biotechnology and pharmaceutical companies create a fertile ground for the adoption of microfluidic cell sorters. The availability of grants and subsidies from government bodies further incentivizes research institutions and companies to invest in advanced cell sorting technologies.

The introduction of the Bench Top Automatic Cell Sorter has revolutionized the way laboratories approach cell sorting tasks. These compact devices are designed to provide high precision and efficiency in sorting cells, making them ideal for smaller research facilities and clinical settings. Their user-friendly interface and automated features reduce the need for extensive operator training, thereby lowering the barrier to entry for many institutions. As the demand for rapid and accurate cell sorting continues to grow, the Bench Top Automatic Cell Sorter stands out as a pivotal tool that combines advanced technology with practical usability. This innovation not only enhances the capabilities of existing research infrastructures but also opens new avenues for exploration in cell-based studies.

Regionally, North America holds a significant share of the global microfluidic cell sorter market, driven by the presence of major biotechnology and pharmaceutical companies, robust research infrastructure, and favorable government policies. Europe follows closely, with a strong focus on research and development and a supportive regulatory environment. The Asia Pacific region is expected to witness the highest growth rate, attributed to increasing healthcare expenditure, rising awareness about advanced diagnostic technologies, and the expansion of biotechnology companies in countries like China and India.

Product Type Analysis

The microfluidic cell sorter market is segmented by product type into Fluorescence-Activated Cell Sorting (FACS), Magnetic-Activated Cell Sorting (MACS), and other sorting techniques. Fluorescence-Activated Cell Sorting (FACS) holds the largest market share due to its high accuracy and efficiency in cell sorting. FACS technology uses fluorescent markers to identify and sort cells based on specific characteristics, making it highly effective for various research and clinical applications. The increasing adoption of FACS in cancer research, stem cell research, and immunology is a significant factor driving its market growth.

Magnetic-Activated Cell Sorting (MACS) is another prominent segment in the microfluidic cell sorter market. MACS technology employs magnetic p

The Global Cell-based Assay Market is anticipated to grow at a CAGR of around 8.4% during the forecast period 2024-29. The global market size is expected to exceed USD 29 billion by 2029.

The Consumer Electronics Optoelectronics Market Report is Segmented by Device Type (LED, Laser Diode, Image Sensors, Optocouplers, Photovoltaic Cells, and Other Device Types) and Geography (United States, Europe, China, Japan, Korea, Taiwan, and the Rest of the World). The Market Sizes and Forecasts are Provided in Terms of Value (USD) for all the Above Segments.

The COVID-19 outbreak is now travelling around the world, leaving a trail of destruction in its wake. This report discusses the impact of the virus on leading companies in the consumer electronics sector. Read More

Cell Harvesting Market size was valued at USD 21.11 Billion in 2024 and is projected to reach USD 30.82 Billion by 2031, growing at a CAGR of 5.34% from 2024 to 2031.

Global Cell Harvesting Market Drivers

Growing Biopharmaceutical Industry: The need for cell harvesting solutions is fueled by the biopharmaceutical industry’s expansion, which is being pushed by rising R&D expenditures, a growing demand for biologics, and improvements in bioprocessing technology. The manufacturing of biologics, such as monoclonal antibodies, vaccines, and cell treatments, which propels market expansion, depends on cell harvesting.

Growing incidence of Chronic Diseases: The need for cell-based therapies and regenerative medicine techniques is driven by the growing incidence of chronic diseases, including cancer, cardiovascular conditions, and autoimmune diseases. Isolating immune, stem, and therapeutic cells from patients or donors for use in cell-based therapies and personalized medicine applications is a critical function of cell harvesting.

Developments in Stem Cell Research: The need for cell harvesting instruments and technologies is driven by the continuous advancements in stem cell research, which include induced pluripotent stem cells (iPSCs), mesenchymal stem cells (MSCs), and hematopoietic stem cells (HSCs). Stem cells can be isolated and expanded for use in tissue engineering, drug discovery, and regenerative medicine through cell harvesting.

Growth in Organ Transplantation and Cell Therapy: The market for cell harvesting is expanding as a result of the rising demand for organ transplantation as well as cell-based therapies for the treatment of genetic disorders, degenerative diseases, and tissue damage. For the objectives of transplantation and therapy, it is necessary to separate cells from tissues, organs, and cell culture systems using cell harvesting procedures.

Technological Developments in Cell Harvesting Methods: Constant innovation and improvement of tools, consumables, and cell harvesting processes improves the yield, efficiency, and purity of harvested cells. Technological developments that enhance cell isolation, viability, and functionality—such as automated cell harvesting systems, microfluidic devices, and magnetic cell separation technologies—fuel industry expansion.

The circular economy is a way of eliminating the shortage of raw materials that Europe is currently facing. However, it is necessary to explicitly identify the problems that prevent greater involvement in the CE. This article is focused on consumers and how they treat discarded or non-functional items. The aim was to fill the research gap, i.e. to compile a suitable CE model and define a methodology that would ensure the efficient disposal of non-functional or unsuitable items by consumers. An original methodology was drawn up to conduct the representative research, designed to lead to the practical application of the proposed CE model. The research explored how consumers treat non-functional or unsuitable items, the costs they incur in discarding, renovating, reusing, and recycling such items, and the alternative costs of unsorted municipal waste. After the data had been implemented into the model the circular economy was proven to have an economic benefit for the national economy in all groups. However, the economic disadvantage for consumers was also calculated, where the cost of involvement in the CE is higher than the cost of unsorted municipal waste. This means that people are motivated to play a part in the CE more by their own responsible approach to life, or social pressure from those around them. Based on this research it may be said that economic aspects are one reason that consumers tend to be reluctant to get more involved in the CE. Unless there is a significant rise in the cost of municipal waste that would motivate consumers to move towards the CE for financial reasons, in order to support the CE consumers need to be better stimulated, educated and informed as much as possible through the media.

The size and share of the market is categorized based on Application (Dyestuff and Pigment Industry, Spice Industry, Pharmaceutical Industry) and Product (Purity 99%, Purity 98%) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

Physical and phytoplankton data were collected using fluorometer and CTD casts in the Northwest Atlantic Ocean from R/V OCEANUS from 18 March 2002 to 31 March 2002. Data were submitted by Dr. Robert J. Olson of Woods Hole Oceanographic Institution (WHOI) to assess the diversity and growth rates of phytoplankton in the northwest Atlantic.

This poll, fielded December 17-20, 2010, solicited respondents' opinion on the United States' world influence, their expectations for themselves and their family in 2011, and whether respondents thought the United States will be more respected by other countries by the end of 2011. They were also queried on whether they thought China's growing economy was a major threat to the economy of the United States, whether respondents thought the United States would have gained ground to China's economy by the end of 2011, whether Americans were more interested in what the country could do for them rather what they could do for their country, and whether most members of Congress were more interested in serving the people they represent or in serving special interest groups. Respondents were queried on their impression of the war in Afghanistan, whether the United States was doing the right thing by fighting the war in Afghanistan, and when United States troops should come home from Afghanistan. They were also asked whether they approved of embryonic stem cell research, whether federal spending on medical research using embryonic stem cells should be increased, decreased, or stay the same, whether illegal immigration was a serious problem, and their views on abortion. They were queried on their favorite holiday song, if they planned to make any New Year's resolutions for 2011, whether they thought they would gain or lose weight over the course of the next year, their preferred Sunday activity for 2011, whether they checked the labels of items to see if they are buying American made products, their frequency in checking e-mail, what they thought of their penmanship, and how frequently they wrote by hand. They were asked whether they had or planned to travel for vacation in the upcoming winter season, whether they were planning to travel some place warm or cold, and whether they thought the weather patterns had been normal or unusual the past few years. Respondents were also asked for their opinion of WikiLeaks, their interest in the 2011 royal wedding, whether they are paid what they think they are worth, whether they have Attention Deficient Disorder, and whether they were proud of their life so far. Demographic information includes sex, age, race, education level, household income, marital status, religious preference, employment status, type of residential area (e.g., urban or rural), political party affiliation, political philosophy, and whether respondent is a born again Christian.

The global cell therapy market is likely to rise from USD 5.93 billion in 2024 to USD 75.37 billion by 2037, reflecting a CAGR of around 21.6% during the forecast timeline, from 2025 to 2037. Key industry players include Novartis AG, Gilead Sciences, Inc., Bristol-Myers Squibb Company, among others.